معرفی
Michal Abrahamowicz, PhD is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and Professor in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University's Faculty of Medicine and Health Sciences. He is affiliated with the Cardiovascular Health Across the Lifespan Program and the Centre for Outcomes Research and Evaluation (CORE) at RI-MUHC.
His research focuses on developing innovative statistical methodologies for clinical and biomedical data analysis, particularly in survival analysis. Key areas include modeling time-varying and cumulative effects of risk factors and treatments, and addressing biases in observational studies. He co-founded and co-chairs the international STRATOS initiative (www.stratos-initiative.org), involving over 100 statisticians from 18 countries, aimed at improving analyses of observational studies. From 2011-2019, he served as Principal Investigator of the CAN-AIM network, funded by the Canadian Institutes for Health Research, which brought together over 45 faculty members from 12 Canadian universities for drug safety and effectiveness research.
His recent publications demonstrate a strong focus on methodological advances in biostatistics, particularly in survival analysis, causal inference, and flexible modeling techniques. His work spans applications in cardiovascular diseases, cancer epidemiology, pharmacoepidemiology, and arthritis research, with an increasing emphasis on practical implementation of statistical methods in clinical research.
Abrahamowicz leads major collaborative research initiatives including large clinical trials and longitudinal population-based studies. His research methodology work directly informs applications in real-world clinical and epidemiological studies, creating a strong bridge between theoretical statistics and practical healthcare research.
